Tumor angiogenesis and dynamic CT in lung adenocarcinoma: Radiologic-pathologic correlation

被引:71
作者
Tateishi, U
Nishihara, H
Watanabe, S
Morikawa, T
Abe, K
Miyasaka, K
机构
[1] Hokkaido Univ, Sch Med, Dept Radiol, Kita Ku, Sapporo, Hokkaido 6068638, Japan
[2] Hokkaido Univ, Sch Med, Dept Pathol 2, Sapporo, Hokkaido 0608638, Japan
[3] Hokkaido Univ, Sch Med, Dept Anat 3, Sapporo, Hokkaido 0608638, Japan
[4] Hokkaido Univ, Sch Med, Dept Surg 2, Sapporo, Hokkaido 0608638, Japan
关键词
lungs; cancer; adenocarcinoma; vascular endothelial growth factor; computed tomography;
D O I
10.1097/00004728-200101000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The purpose of this work was to evaluate the correlation of tumor angiogenesis and dynamic CT in lung adenocarcinoma. Method: Thirty-five consecutive patients with lung adenocarcinoma underwent dynamic chest CT. Maximum attenuation of dynamic CT was compared with microvessel densities (MVDs) and vascular endothelial growth factor (VEGF) expression by immunohistochemistry. Results: The mean peak attenuation (A(PA)) of lung adenocarcinoma correlated with MVD (r = 0.689. p < 0.0001). VEGF positiveness of lung adenocarcinoma was 63%. There was a significant difference in A(PA) between VEGF-positive and -negative lung adenocarcinomas (39.9 +/- 3.9 and 23.3 +/- 2.3: p < 0.05). The mean MVDs of VEGF-positive adenocarcinomas were significantly higher than those of negative ones (82.5 +/- 5.9 and 49.2 +/- 7.1, p < 0.05). The mean A(PA) of VEGF-positive lung adenocarcinomas correlated positively with MVD (r = 0.707, p < 0.0001). Conclusion: The A(PA) value of dynamic CT reflects MVD in lung adenocarcinoma. The A(PA) value of dynamic CT might be an index for VEGF-related tumor angiogenesis.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 15 条
[1]  
CRDKOWITZ L, 1953, THORAX, V8, P152
[2]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[3]  
Fontanini G, 1997, CLIN CANCER RES, V3, P861
[4]   Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas [J].
Fontanini, G ;
Boldrini, L ;
Chinè, S ;
Pisaturo, F ;
Basolo, F ;
Calcinai, A ;
Lucchi, M ;
Mussi, A ;
Angeletti, CA ;
Bevilacqua, G .
BRITISH JOURNAL OF CANCER, 1999, 79 (02) :363-369
[5]   Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression [J].
Fontanini, G ;
Vignati, S ;
Lucchi, M ;
Mussi, A ;
Calcinai, A ;
Boldrini, L ;
Chine, S ;
Silvestri, V ;
Angeletti, CA ;
Basolo, F ;
Bevilacqua, G .
BRITISH JOURNAL OF CANCER, 1997, 75 (09) :1295-1301
[6]   PULMONARY MASSES - CONTRAST ENHANCEMENT [J].
LITTLETON, JT ;
DURIZCH, ML ;
MOELLER, G ;
HERBERT, DE .
RADIOLOGY, 1990, 177 (03) :861-871
[7]   Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer [J].
Maniwa, Y ;
Okada, M ;
Ishii, N ;
Kiyooka, K .
CHEST, 1998, 114 (06) :1668-1675
[8]  
MATTERN J, 1995, INT J ONCOL, V6, P1059
[9]   Vascular endothelial growth factor and lymph node metastasis in primary lung cancer [J].
Ohta, Y ;
Watanabe, Y ;
Murakami, S ;
Oda, M ;
Hayashi, Y ;
Nonomura, A ;
Endo, Y ;
Sasaki, T .
BRITISH JOURNAL OF CANCER, 1997, 76 (08) :1041-1045
[10]  
Ohta Y, 1996, CLIN CANCER RES, V2, P1411